Stock listing
Alpha Tau Medical Ltd
Selected listing: DRTS · NASDAQ · USD · US
Alpha Tau Medical Ltd (NASDAQ:DRTS), Health Technology. Latest release Oct 5, 2026: Alpha Tau to Participate in October Investor Conferences.
- Ticker
- NASDAQ:DRTS
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- NASDAQ
- Currency
- USD
About Alpha Tau Medical Ltd
Alpha Tau Medical Ltd. is a public company traded under the ticker DRTS in the American market. Alpha Tau focuses on innovative medical technologies, particularly in the field of cancer treatment.
Latest news from Alpha Tau Medical Ltd
Alpha Tau to Participate in October Investor Conferences
October 5, 2026
Alpha Tau to Participate in September Investor Conferences
September 2, 2026
Alpha Tau Completes Patient Enrollment in its Multicenter IMPACT Pancreatic Cancer Pilot Study of Alpha DaRT® Following Strong Demand and Multiple Expansions
August 31, 2026
Alpha Tau Announces Second Quarter 2026 Financial Results and Provides Corporate Update
August 10, 2026
Alpha Tau Reports Positive Data Demonstrating 100% Objective Response Rate and 18.2-Month Median Overall Survival with Alpha DaRT® in Combination with Pembrolizumab in Locally Advanced or Metastatic Head and Neck Cancer, Surpassing the Study's Pre-Specified Threshold for Success
July 21, 2026
Research Alpha Tau Medical Ltd
Alpha Tau Medical Ltd company profile
View the public company page for Alpha Tau Medical Ltd on 6ix.
Alpha Tau Medical Ltd news
Read company news and market updates connected to Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd investor events
Find investor webinars, events, and replay context for Alpha Tau Medical Ltd.